Abstract:The aggregation of soluble amyloid‐beta (Aβ) peptide into oligomers/fibrils is one of the key pathological features in Alzheimer's disease (AD). The Aβ aggregates are considered to play a pivotal role in the pathogenesis of AD. Therefore, inhibiting Aβ aggregation and destabilizing preformed Aβ fibrils would be an attractive therapeutic target for prevention and treatment of AD. S14G‐humanin (HNG), a synthetic derivative of Humanin (HN), has been shown to be a strong neuroprotective agent against various AD‐related insults. Recent studies have shown that HNG can significantly improve cognitive deficits and reduce insoluble Aβ levels as well as amyloid plaque burden without affecting amyloid precursor protein processing and Aβ production in transgenic AD models. However, the potential mechanisms by which HNG reduces Aβ‐related pathology in vivo remain obscure. In the present study, we found that HNG could significantly inhibit monomeric Aβ1–42 aggregation into fibrils and destabilize preformed Aβ1–42 fibrils in a concentration‐dependent manner by Thioflavin T fluorescence assay. In transmission electron microscope study, we observed that HNG was effective in inhibiting Aβ1–42 fibril formation and disrupting preformed Aβ1–42 fibrils, exhibiting various types of amorphous aggregates without identifiable Aβ fibrils. Furthermore, HNG‐treated monomeric or fibrillar Aβ1–42 was found to significantly reduce Aβ1–42‐mediated cytotoxic effects on PC12 cells in a dose‐dependent manner by MTT assay. Collectively, our results demonstrate for the first time that HNG not only inhibits Aβ1–42 fibril formation but also disaggregates preformed Aβ1–42 fibrils, which provides the novel evidence that HNG may have anti‐Aβ aggregation and fibrillogenesis, and fibril‐destabilizing properties. Together with previous studies, we concluded that HNG may have promising therapeutic potential as a multitarget agent for the prevention and/or treatment of AD. Copyright © 2013 European Peptide Society and John Wiley & Sons, Ltd.

Central Effects of Humanin on Hepatic Triglyceride Secretion

Humanin prevents high glucose-induced monocyte adhesion to endothelial cells by targeting KLF2.

[Gly14]-Humanin Prevents Lipid Deposition And Endothelial Cell Apoptosis In A Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1-Dependent Manner

[Gly14]-Humanin Ameliorates High Glucose-Induced Apoptosis by Inhibiting the Expression of MicroRNA-155 in Endothelial Microparticles

Humanin Analogue, HNG, Inhibits Platelet Activation and Thrombus Formation by Stabilizing Platelet Microtubules

Humanin Prevents Intra-Renal Microvascular Remodeling and Inflammation in Hypercholesterolemic Apoe Deficient Mice

Protection effect of [Gly14]-Humanin from apoptosis induced by high glucose in human umbilical vein endothelial cells.

Gly[14]-humanin Inhibits Ox-Ldl Uptake and Stimulates Cholesterol Efflux in Macrophage-Derived Foam Cells.

Protective effects of [Gly14]-Humanin on β-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction

Effect of humanin and [Gly14]-humanin on expression of hippocampal glial fibrillary acidic protein in mice with Alzheimer disease

RETRACTED: S14G-Humanin Ameliorates Aβ25-35-induced Behavioral Deficits by Reducing Neuroinflammatory Responses and Apoptosis in Mice

[Gly14]-Humanin Reduces Histopathology and Improves Functional Outcome after Traumatic Brain Injury in Mice.

S14G-Humanin Improves Cognitive Deficits and Reduces Amyloid Pathology in the Middle-Aged APPswe/PS1dE9 Mice

[Gly14]-Humanin Restores Cathepsin D Function Via FPRL1 and Promotes Autophagic Degradation of Ox-LDL in HUVECs.

[Gly14]-Humanin Offers Neuroprotection Through Glycogen Synthase Kinase-3Β Inhibition in a Mouse Model of Intracerebral Hemorrhage

Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice

[Gly14]-humanin exerts a protective effect against D-galactose-induced primary ovarian insufficiency in mice

[Gly14]-Humanin Inhibits an Angiotensin II-induced Vascular Smooth Muscle Cell Phenotypic Switch Via Ameliorating Intracellular Oxidative Stress

Retracted: S14G‐humanin Inhibits Aβ1–42 Fibril Formation, Disaggregates Preformed Fibrils, and Protects Against Aβ‐induced Cytotoxicity in Vitro

Protective Effect of S14G-humanin Against Beta-Amyloid Induced LTP Inhibition in Mouse Hippocampal Slices.

S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.